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Somatic reversions of inherited mutations in adenosine 
deaminase deficiency, X-linked severe combined 
immunodeficiency (X-SCID), and Wiskott-Aldrich 
syndrome have been recognized in humans. These 
reversions are caused by either back mutations, with 
restoration of wild-type sequence, or second-site 
mutations, leading to compensatory changes. These 
mutations have been associated with milder clinical 
phenotypes in these primary T cell immunodeficiencies. 
Leukocyte adhesion deficiency Type I (LAD-I) is an 
autosomal recessive immunodeficiency affecting leuko- 
cyte adhesion caused by heterogeneous mutations in the 
PZ integrin, CDlS.These mutations prevent for mation 
of CDllKD18 heterodimers and surface expression of 
the receptor complex. Defective or absent CD18 on 
leukocytes, particularly neutrophils, leads to defective 
adherence to the endothelium and failure to migrate to 
the site of infection. 
Three moderately affected LAD-l patients were 
studied by flow cytometry. As expected, neutrophil CD18 
expression was markedly and homogeneously diminished 
compared to normals. However, we were surprised to 
find that each of these patients had a small subset of 
lymphocytes with normal CD18 expression (CD18+). 
These CD18+ lymphocytes were CD3+/CD8+/CD57+, 
representing potential cytotoxic T cells (CTL). 
CD3+/CD18+ and CD3+/CD18- lymphocytes from 
each patient were sorted using FACS Vantage (Becton- 
Dickinson) and genomic DNA was obtained. Micro- 
satellite analysis proved patient origin of CD18+ cells 
in each case. Subcloning and sequencing showed 
heterozygous reversion mutations in patients 1 and 2, 
and back mutation on one of patient 3’s alleles leading 
to correction of his splicing defect (Table).Although the 
reversions in patient 1 and 2 are not to the exact wild 
type (wt), but to a third amino acid, they support LFA- 
1 expression, and the expressed LFA-1 behaves like wt. 
Somatic reversions conferring CD18+ expression in 
these patients were detected primarily in CD3+/CD8+/ 
CD57+ cells. This suggests that somatic revertant 
CD18+ CTLs may have a survival advantage in LAD-l. 
Whether these revertant CD18+ CTL confer advantages 
on the host ameliorating disease awaits ongoing func- 
tional studies. The identification of 3 cases of reversion 
mutations in moderate LAD-l at one center suggests 
Patient No.1 
Age, Sex 
Patient 1 19y M 
Patient 2 22y F 
Patient 3 31y M 
Mutation 
Nucleotide: 
amino acid 
A392C: Y131S 
G850A: G2845 
A1052G: N3515 and 
C-A-1 2 741: 247+ PSSQ 
Patient No./ 
Age, Sex 
Patient 1 19y M 
Patient 2 22y F 
Patient 3 31y M 
Reversion % CD78+ 
Amino acid change lymphocytes 
Y131F 5 
G284R 7 
20 
C-12 741: 2474 
that this may be a relatively common event in this rare 
disease. Finally, this is the first identified series for 
somatic reversion in a primary phagocyte defect. 
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Background: Genetic susceptibility factors have been 
recognized to play a critical role in otherwise healthy 
individuals who develop disseminated nontuberculous 
mycobacterial (DNTM) infections. Exonic and intronic 
mutations in the interferon-y receptor 1 (IFNGRl) gene 
are among them. In contrast, no inherited susceptibility 
factors have been yet associated with pulmonary non- 
tuberculous mycobacterial (PNTM) infections. 
Methods: We sequenced the IFNGRl minimal promoter 
region (MPR) of 55 Caucasian patients with NTM in- 
fections, 17 disseminated and 38 pulmonary. No patients 
with known susceptibility factors to NTM were included. 
We also sequenced 86 Caucasian controls. We compared 
single nucleotide polymorphisms (SNPs) and inferred 
haplotype distributions between populations. 
Findings: We identified 10 previously undescribed 
SNPs in the IFNGRl MPR, two of which show strong 
statistical association with NTM infections in patients 
without other risk factors. Compared to controls, the 
polymorphisms -6llA and -56C were significantly over- 
represented in patients with DNTM infections (p=O.O04 
and 0.03, respectively), whereas polymorphism -6llA 
was significantly over-represented in patients with 
PNTM infections @=O.OOOl).The probability of finding 
